Nearly half of the patients at Johns Hopkins Aramco Healthcare (JHAH), Johns Hopkins Medicine's joint venture in Saudi Arabia, are at increased risk for diabetes, obesity and cardiovascular diseases. While these conditions are highly prevalent in Saudi Arabia, we’re working hard to limit them.
Implementing lifestyle medicine principles—making more informed decisions about nutrition, exercise and the environment—can reduce mortality and risk factors related to chronic disease.
Johns Hopkins Medicine International has begun working with JHAH to integrate lifestyle medicine into all stages of patient care and create a lasting model to reduce the likelihood and impact of chronic disease. Our teams are working together to identify and reduce risk factors and treat high blood pressure, type 2 diabetes and high cholesterol.
“If we want to guide patients in Saudi Arabia and across the region toward better health, we have to increase prevention efforts and improve population health,” says Felicia Hill-Briggs, senior director of population health research and development at Johns Hopkins Medicine, who we've tapped to help guide these important efforts.
This post highlights content from JHI’s FY17-FY18 Impact Report, Realizing the Mission. Read the full report and check out this video to learn more about our transformational work in international collaborative health from the last two fiscal years.
